These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 12175744
21. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release. Liang D, Frank S, Schwendeman SP. Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895 [Abstract] [Full Text] [Related]
22. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers. Geze A, Venier-Julienne MC, Saulnier P, Varlet P, Daumas-Duport C, Devauchelle P, Benoit JP. J Control Release; 1999 Apr 19; 58(3):311-22. PubMed ID: 10099156 [Abstract] [Full Text] [Related]
23. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere. Su Z, Sun F, Shi Y, Jiang C, Meng Q, Teng L, Li Y. Chem Pharm Bull (Tokyo); 2009 Nov 19; 57(11):1251-6. PubMed ID: 19881277 [Abstract] [Full Text] [Related]
24. Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months. Kazazi-Hyseni F, Landin M, Lathuile A, Veldhuis GJ, Rahimian S, Hennink WE, Kok RJ, van Nostrum CF. Pharm Res; 2014 Oct 19; 31(10):2844-56. PubMed ID: 24825756 [Abstract] [Full Text] [Related]
25. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method. Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP. Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832 [Abstract] [Full Text] [Related]
26. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. Rosa GD, Iommelli R, La Rotonda MI, Miro A, Quaglia F. J Control Release; 2000 Nov 03; 69(2):283-95. PubMed ID: 11064135 [Abstract] [Full Text] [Related]
27. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A. Malaekeh-Nikouei B, Sajadi Tabassi SA, Jaafari MR. Curr Drug Deliv; 2006 Oct 03; 3(4):343-9. PubMed ID: 17076635 [Abstract] [Full Text] [Related]
28. Size effect of PLGA spheres on drug loading efficiency and release profiles. Dawes GJ, Fratila-Apachitei LE, Mulia K, Apachitei I, Witkamp GJ, Duszczyk J. J Mater Sci Mater Med; 2009 May 03; 20(5):1089-94. PubMed ID: 19160026 [Abstract] [Full Text] [Related]
29. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. Uchida T, Yagi A, Oda Y, Nakada Y, Goto S. Chem Pharm Bull (Tokyo); 1996 Jan 03; 44(1):235-6. PubMed ID: 8582042 [Abstract] [Full Text] [Related]
30. Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. Chen W, Lu DR. J Microencapsul; 1999 Jan 03; 16(5):551-63. PubMed ID: 10499836 [Abstract] [Full Text] [Related]
31. Sustained release microspheres of metoclopramide using poly(D,L-lactide-co-glycolide) copolymers. Elkheshen SA, Radwan MA. J Microencapsul; 2000 Jan 03; 17(4):425-35. PubMed ID: 10898083 [Abstract] [Full Text] [Related]
32. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Int J Pharm; 2007 Apr 04; 334(1-2):137-48. PubMed ID: 17196348 [Abstract] [Full Text] [Related]
33. Ethyl acetate as a dispersing solvent in the production of poly(DL-lactide-co-glycolide) microspheres: effect of process parameters and polymer type. Soppimath KS, Aminabhavi TM. J Microencapsul; 2002 Apr 04; 19(3):281-92. PubMed ID: 12022494 [Abstract] [Full Text] [Related]
34. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis. Cevher E, Orhan Z, Sensoy D, Ahiskali R, Kan PL, Sağirli O, Mülazimoğlu L. J Microencapsul; 2007 Sep 04; 24(6):577-95. PubMed ID: 17654177 [Abstract] [Full Text] [Related]
35. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Bittner B, Morlock M, Koll H, Winter G, Kissel T. Eur J Pharm Biopharm; 1998 May 04; 45(3):295-305. PubMed ID: 9653634 [Abstract] [Full Text] [Related]
36. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. McCarron PA, Donnelly RF, Marouf W. J Microencapsul; 2006 Aug 04; 23(5):480-98. PubMed ID: 16980271 [Abstract] [Full Text] [Related]
37. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Shenderova A, Burke TG, Schwendeman SP. Pharm Res; 1997 Oct 04; 14(10):1406-14. PubMed ID: 9358554 [Abstract] [Full Text] [Related]
38. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes. De Rosa G, Quaglia F, La Rotonda MI, Appel M, Alphandary H, Fattal E. J Pharm Sci; 2002 Mar 04; 91(3):790-9. PubMed ID: 11920765 [Abstract] [Full Text] [Related]
39. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load. Ravivarapu HB, Lee H, DeLuca PP. Pharm Dev Technol; 2000 Mar 04; 5(2):287-96. PubMed ID: 10810758 [Abstract] [Full Text] [Related]
40. One-step surface modification of poly(lactide-co-glycolide) microparticles with heparin. Cui C, Schwendeman SP. Pharm Res; 2007 Dec 04; 24(12):2381-93. PubMed ID: 17710516 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]